logo

Sage Therapeutics, Inc. (SAGE)



Trade SAGE now with
  Date
  Headline
2/8/2018 10:16:04 PM Sage Therapeutics Prices Offering Of 3.51 Mln Shares At $164.00/shr
2/7/2018 6:32:45 AM Sage Therapeutics Receives FDA Breakthrough Therapy Designation For SAGE-217 For Major Depressive Disorder
1/31/2018 6:08:07 AM Sage Therapeutics Announces Positive Results From Placebo-Controlled Trial; SAGE-217 Meets Primary Endpoint
12/28/2017 4:26:12 AM Watch These 6 Biotech Stocks
12/7/2017 6:12:36 AM Sage Therapeutics Announces Positive Top-line Results From Phase 2 Placebo-controlled Clinical Trial Of SAGE-217
11/27/2017 12:02:55 PM RBC Capital Markets Is Raising SAGE Therapeutics, Inc. (SAGE) FY19 Rev. Estimate To 172.8 M From 165.3 M
11/27/2017 12:02:36 PM RBC Capital Markets Is Increasing SAGE Therapeutics, Inc. (SAGE) FY18 Rev. Estimate To 83.8 M From 76.3 M
11/27/2017 12:02:03 PM RBC Capital Markets Is Raising SAGE Therapeutics, Inc. (SAGE) FY19 Estimate To -5.92 From -6.17
11/27/2017 12:01:45 PM RBC Capital Markets Is Raising SAGE Therapeutics, Inc. (SAGE) FY18 Estimate To -6.28 From -6.55
11/27/2017 12:01:26 PM RBC Capital Markets Is Raising SAGE Therapeutics, Inc. (SAGE) FY17 Estimate To -7.19 From -7.22
11/27/2017 12:01:07 PM RBC Capital Markets Is Increasing SAGE Therapeutics, Inc. (SAGE) Q4 17 Estimate To -1.81 From -1.85